Skip to content
by Legal Desire
21 October 2026

DLA Piper advises Arlington Capital Partners and Everest Clinical Research on acquisition of Firma Clinical Research unit

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Jeffrey Houle Lead DLA Piper Partner Aerospace, Defense and Government Services Transactional Not stated
Thomas Pilkerton DLA Piper Partner Not stated Baltimore
Paul Nolle DLA Piper Partner Not stated Short Hills
Russel Drew DLA Piper Partner Not stated Toronto
Donato Rosati DLA Piper Associate Not stated Toronto
Nathaniel McKitterick DLA Piper Partner Not stated Palo Alto
William Bartow DLA Piper Partner Not stated Not stated
Jae Kim DLA Piper Partner Not stated Philadelphia
C. Kevin Kobbe DLA Piper Partner Not stated Baltimore
Julia Kovacs DLA Piper Partner Not stated Washington, DC
Tracy Weir DLA Piper Partner Not stated Washington, DC
James Rusert DLA Piper Partner Not stated Atlanta
Sue Zabloudil DLA Piper Partner Not stated Miami
Cara Hupprich DLA Piper Other Not stated Reston
Xana Connelly DLA Piper Other Not stated San Juan
Traneke Hamrick DLA Piper Associate Not stated Washington, DC

13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Arlington Capital Partners and Everest Clinical ResearchBuy-side
Counterparties
Firma Clinical Research (Sell-side)